Skip to content
10-Q

Quarterly Report

PLANDAI BIOTECHNOLOGY, INC.

0001262463-16-000997

← back to feed
Filed
Jul 29, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · Jul 13, 2016 186.53M sh
Capex Q1 2016 · Sep 30, 2015 $5.77K
Capex restated Q1 2016 · Sep 30, 2014 $104.33K
Operating Cash Flow Q1 2016 · Sep 30, 2015 −$288.48K
Operating Cash Flow restated Q1 2016 · Sep 30, 2014 $7.28K
Cash And Equivalents Q1 2016 · Sep 30, 2015 $5.56K
Cash And Equivalents Q1 2016 · Jun 30, 2015 $33.62K
Cash And Equivalents Q1 2016 · Sep 30, 2014 $1.48M
Cash And Equivalents restated Q1 2016 · Jun 30, 2014 $156.33K
Stockholders Equity Q1 2016 · Sep 30, 2015 −$7.21M
Stockholders Equity Q1 2016 · Jun 30, 2015 −$6.5M
Current Liabilities Q1 2016 · Sep 30, 2015 $14.8M
Current Liabilities Q1 2016 · Jun 30, 2015 $15.15M
Total Liabilities Q1 2016 · Sep 30, 2015 $16.36M
Total Liabilities Q1 2016 · Jun 30, 2015 $16.82M
Current Assets Q1 2016 · Sep 30, 2015 $142.59K
Current Assets Q1 2016 · Jun 30, 2015 $418.16K
Total Assets Q1 2016 · Sep 30, 2015 $7.22M
Total Assets Q1 2016 · Jun 30, 2015 $8.5M
Sga Expense Q1 2016 · Sep 30, 2015 $123.45K
Sga Expense restated Q1 2016 · Sep 30, 2014 $636.19K
Net Income Q1 2016 · Sep 30, 2015 −$1.19M
Net Income Q1 2016 · Sep 30, 2014 −$610.96K
Operating Income Q1 2016 · Sep 30, 2015 −$879.17K
Operating Income Q1 2016 · Sep 30, 2014 −$1.47M
Revenue Q1 2016 · Sep 30, 2015 $40.83K
Revenue Q1 2016 · Sep 30, 2014 $26.39K